EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:753987 - epoetin beta
| ChEBI ID | CHEBI:753987 |
| ChEBI Name | epoetin beta |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | chembl-etl |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| epoetin beta (CHEBI:753987) has role anti-anaemic agent (CHEBI:75835) |
| epoetin beta (CHEBI:753987) has role antimalarial (CHEBI:38068) |
| epoetin beta (CHEBI:753987) has role antineoplastic agent (CHEBI:35610) |
| epoetin beta (CHEBI:753987) has role antiparkinson drug (CHEBI:48407) |
| epoetin beta (CHEBI:753987) has role antipsychotic agent (CHEBI:35476) |
| epoetin beta (CHEBI:753987) has role antiviral agent (CHEBI:22587) |
| epoetin beta (CHEBI:753987) has role cardiovascular drug (CHEBI:35554) |
| epoetin beta (CHEBI:753987) has role immunosuppressive agent (CHEBI:35705) |
| epoetin beta (CHEBI:753987) has role neuroprotective agent (CHEBI:63726) |
| epoetin beta (CHEBI:753987) has role renoprotective agent (CHEBI:231911) |
| epoetin beta (CHEBI:753987) has role vulnerary (CHEBI:73336) |
| epoetin beta (CHEBI:753987) is a organic molecular entity (CHEBI:50860) |
| INNs | Source |
|---|---|
| epoetina beta | WHO MedNet |
| epoetine beta | WHO MedNet |
| Synonyms | Source |
|---|---|
| BM 06.019 | ChEMBL |
| EPOCH | ChEMBL |
| Epoetin beta | ChEMBL |
| Brand Names | Source |
|---|---|
| Neorecormon | ChEMBL |
| Neorecormon 1000 | ChEMBL |
| Neorecormon 10000 | ChEMBL |
| Neorecormon 2000 | ChEMBL |
| Neorecormon 20000 | ChEMBL |
| Neorecormon 3000 | ChEMBL |